LinkedIn facebook twitter youtube
News archive
Recent news

More than 12.600 people attended the European Hematology Association (EHA) Annual Meeting, the largest EHA Congress ever recorded with a growth of more than a thousand participants from last year. EHA 2019 was held from 13 to 16 June in Amsterdam, The Netherlands where 360 presentations and more than 1300 posters were presented to update the latest development in haematology.

Regarding myeloma, new drugs and key updates were presented during this congress. Dr Laurent Garderet, Department of Hematology at Pitié Salpêtrière Hospital in Paris, France, summarises the most important myeloma topics presented during this important scientific meeting.

Find below this video below or watch it on our YouTube Channel:


Find below the EHA 2019 photo gallery:


24th EHA Annual Meeting
« of 98 »

Recent news

» Melflufen receives positive opinion from the European Medicines Agency (EMA) for the treatment of refractory myeloma

» EHA 2022 highlights in myeloma and AL amyloidosis

2 Responses to EHA 2019 myeloma highlights

  • An extremly well prepared education program for Patient Advocates. People make the difference – so many highly motivated people in one place.
    Great to be one of the team!

  • Amsterdam Congress was a real highlight, presenting most qualified specialists for hematology who shared their knowledge with us! Thank you so much for having been given the opportunity to be a part of it!

Leave a Reply

Your email address will not be published.

I accept the Privacy Policy